Marijuana practices and patterns of use among young adult medical marijuana patients and non-patient marijuana users

Drug and Alcohol Dependence

Volumn 170, Issue , 2017, Pages 181-188

  Lankenau, Stephen E ^a   Fedorova, Ekaterina V ^a   Reed, Megan ^a   Schrager, Sheree M ^c   Iverson, Ellen ^b,c   Wong, Carolyn F ^b,c  

^a DREXEL UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Drug use; Medical marijuana; Young adults

Indexed keywords

MEDICAL CANNABIS; CANNABIS;

ADULT; ARTICLE; CANNABIS USE; DRUG MARKETING; DRUG MISUSE; DRUG TRAFFIC; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT; PRESCRIPTION; PRIORITY JOURNAL; SELF REPORT; VAPORIZATION; YOUNG ADULT; ADOLESCENT; CALIFORNIA; CANNABIS SMOKING; PSYCHOLOGY;

ADOLESCENT; ADULT; CANNABIS; FEMALE; HUMANS; LOS ANGELES; MALE; MARIJUANA SMOKING; MEDICAL MARIJUANA; PRESCRIPTION DRUG MISUSE; YOUNG ADULT;

EID: 85004044972     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2016.10.025     Document Type: Article

References (50)

1. Abrams, D.I., Vizoso, H.P., Shade, S.B., Jay, C., Kelly, M.E., Benowitz, N.L., Vaporization as a smokeless cannabis delivery system: a pilot study. Clin. Pharmacol. Ther. 82 (2007), 572–578, 10.1038/sj.clpt.6100200.
2. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57 (1995), 289–300.
3. Biernacki, P., Waldorf, D., Snowball sampling: problems, techniques and chain-referral sampling. Sociol. Method Res. 10 (1981), 141–163.
4. Black, B., The Official Dab Dictionary. 2013, High Times http://www.hightimes.com/read/official-dab-dictionary (retrieved 06.23.16).
5. Bonn-Miller, M.O., Boden, M.T., Bucossi, M.M., Babson, K.A., Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am. J. Drug Alcohol Abuse 40 (2014), 23–30, 10.3109/00952990.2013.821477.
6. Budney, A.J., Sargent, J.D., Lee, D.C., Confirmation of the trials and tribulations of vaping. Addiction 110 (2015), 1699–1704.
7. Center for Behavioral Health Statistics and Quality, 2015. Behavioral Health Trends In The United States: Results From The 2014 National Survey On Drug Use And Health. HHS Publication No. SMA 15-4927, NSDUH Series H-50. 2015.
8. Chapkis, W., Webb, R.J., Dying to Get High: Marijuana as Medicine. 2008, New York University, New York.
9. Compton, W.M., Jones, C.M., Baldwin, G.T., Relationship between nonmedical prescription-opioid use and heroin use. N. Engl. J. Med. 374 (2016), 154–163, 10.1056/NEJMra1508490.
10. Daniulaityte, R., Nahhas, R.W., Wijeratne, S., Carlson, R.G., Lamy, F.R., Martins, S.S., Boyer, E.W., Smith, G.A., Sheth, A., Time for dabs: analyzing Twitter data on marijuana concentrates across the U.S. Drug Alcohol Depend. 155 (2015), 307–311, 10.1016/j.drugalcdep.2015.07.1199.
11. Dreher, M., Crack heads and roots daughters: the therapeutic use of cannabis in Jamaica. J. Cannabis Ther. 2 (2002), 121–133, 10.1300/J175v02n03_08.
12. Gartner, C., Mull it over: cannabis vaporizers and harm reduction. Addiction 110 (2015), 1709–1710, 10.1186/s12916-014-0264-5.1709.
13. Gieringer, D.H., Cannabis vaporization: a promising strategy for smoke harm reduction. J. Cannabis Ther. 1 (2001), 153–170.
14. Gieringer, D.H., Medical use of cannabis: experience in California. Grotenhermen, F., Russo, E., (eds.) Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential, 2002, Haworth Integrative Healing Press, New York, 143–151.
15. Grella, C.E., Rodriguez, L., Kim, T., Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in Los Angeles. J. Psychoact. Drugs 46 (2014), 263–272, 10.1080/02791072.2014.944960.
16. Harris, K.M., Halpern, C.T., Whitsel, E., Hussey, J., Tabor, J., Entzel, P., Udry, J.R., The National Longitudinal Study of Adolescent to Adult Health: Research Design. 2009 URL: http://www.cpc.unc.edu/projects/addhealth/design (WWW document).
17. Harrison, L.D., Erickson, P.G., Korf, D.J., Brochu, S., Benschop, A., How much for a dime bag? An exploration of youth drug markets. Drug Alcohol Depend. 90:Suppl. 1 (2007), S27–S39, 10.1016/j.drugalcdep.2006.09.009.
18. Kelly, B.C., Bongs and blunts: notes from a suburban marijuana subculture. J. Ethn. Subst. Abuse 4 (2005), 81–97, 10.1300/J233v04n03.
19. Lankenau, S.E., Schrager, S.M., Silva, K., Kecojevic, A., Bloom, J.J., Wong, C., Iverson, E., Misuse of prescription and illicit drugs among high-risk young adults in Los Angeles and New York. J. Public Health Res. 1 (2012), 22–30.
20. Lanz, C., Mattsson, J., Soydaner, U., Brenneisen, R., Medicinal cannabis: in vitro validation of vaporizers for the smoke-free inhalation of cannabis. PLoS One, 11, 2016, e0147286, 10.1371/journal.pone.0147286.
21. Lau, N., Sales, P., Averill, S., Murphy, F., Sato, S.O., Murphy, S., A safer alternative: cannabis substitution as harm reduction. Drug Alcohol Rev. 34 (2015), 654–659, 10.1111/dar.12275.
22. Lucas, P., Walsh, Z., Crosby, K., Callaway, R., Belle-Isle, L., Kay, R., Capler, R., Holtzman, S., Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: the impact of contextual factors. Drug Alcohol Rev. 35 (2016), 326–333, 10.1111/dar.12323.
23. McCabe, S.E., Boyd, C.J., Teter, C.J., Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend. 102 (2009), 63–70.
24. McCabe, C.J., Louie, K.A., King, K.M., Premeditation moderates the relation between sensation seeking and risky substance use among young adults. Psychol. Addict. Behav. 29 (2015), 753–765.
25. Mikuriya, T.H., Hergenrather, J., Denney, P., et al. Medical marijuana in california, 1996–2006. J. Cannabis Clin. Pract. Winter/Spr, 2007, 1–4.
26. Mikuriya, T.H., Cannabis as a substitute for alcohol: a harm-reduction approach. J. Cannabis Ther. 4 (2004), 79–93, 10.1300/J175v04n01_04.
27. Moonzwe, L.S., Schensul, J.J., Kostick, K.M., The role of MDMA (ecstasy) in coping with negativ life event situations among urban young adults. J. Psychoact. Drugs 43 (2011), 199–210, 10.1038/nature13314.A.
28. Murphy, F., Sales, P., Murphy, S., Averill, S., Lau, N., Sato, S.-O., Baby boomers and cannabis delivery systems. J. Drug Issues 45 (2015), 292–313, 10.1108/17506200710779521.
29. Nussbaum, A.M., Thurstone, C., McGarry, L., Walker, B., Sabel, A.L., Use and diversion of medical marijuana among adults admitted to inpatient psychiatry. Am. J. Drug Alcohol Abuse 42 (2014), 166–172, 10.3109/00952990.2014.949727.
30. Pacula, R.L., Jacobson, M., Maksabedian, E.J., In the weeds: a baseline view of cannabis use among legalizing states and their neighbours. Addiction 111 (2016), 973–980, 10.1111/add.13282.
31. Patrick, M.E., O'Malley, P.M., Kloska, D.D., Schulenberg, J.E., Johnston, L.D., Miech, R.A., Bachman, J.G., Novel psychoactive substance use by US adolescents: characteristics associated with use of synthetic cannabinoids and synthetic cathinones. Drug Alcohol Rev. 35 (2015), 586–590.
32. Pearce, D.D., Mitsouras, K., Irizarry, K.J., Discriminating the effects of cannabis sativa and cannabis indica: a web survey of medical cannabis users. J. Altern. Complement. Med. 20 (2014), 787–791, 10.1089/acm.2013.0190.
33. Raber, J.C., Elzinga, S., Kaplan, C., Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. J. Toxicol. Sci. 40 (2015), 797–803, 10.2131/jts.40.797.
34. Reiman, A.E., Self-efficacy, social support and service integration at medical cannabis facilities in the San Francisco Bay area of California. Health Soc. Care Community 16 (2008), 31–41, 10.1111/j.1365-2524.2007.00722.x.
35. Reiman, A., Cannabis as a substitute for alcohol and other drugs. Harm Reduct. J., 6, 2009, 35, 10.1186/1477-7517-6-35.
36. Richmond, M.K., Pampel, F.C., Rivera, L.S., Broderick, K.B., Reimann, B., Fischer, L., Frequency and risk of marijuana use among substance-using health care patients in Colorado with and without access to state legalized medical marijuana. J. Psychoact. Drugs 47 (2015), 1–9, 10.1080/02791072.2014.991008.
37. Roy-Byrne, P., Maynard, C., Bumgardner, K., Krupski, A., Dunn, C., West, I.I., Donovan, D., Atkins, D.C., Ries, R., Are medical marijuana users different from recreational users? The view from primary care. Am. J. Addict. 24 (2015), 599–606, 10.1111/ajad.12270.
38. Ryan-Ibarra, S., Induni, M., Ewing, D., Prevalence of medical marijuana use in California, 2012. Drug Alcohol Rev., 2014, 10.1111/dar.12207.
39. Schauer, G.L., King, B.A., Bunnell, R.E., Promoff, G., McAfee, T.A., Toking, vaping, and eating for health or fun. Am. J. Prev. Med. 50 (2016), 1–8, 10.1016/j.amepre.2015.05.027.
40. Sifaneck, S.J., Kaplan, C.D., Keeping off, stepping on and stepping off: the steppingstone theory reevaluated in the context of the Dutch cannabis experience. Contemp. Drug Probl. 22 (1995), 483–513.
41. Sifaneck, S.J., Kaplan, C.D., Dunlap, E., Johnson, B.D., Blunts and blowtjes: cannabis use practices in two cultural settings and their implications for secondary prevention. Free Inq. Creat. Sociol. 31 (2003), 3–14.
42. Sifaneck, S.J., Johnson, B.D., Dunlap, E., Cigars-for-blunts: choice of tobacco products by blunt smokers. J. Ethn. Subst. Abuse 4 (2005), 23–42, 10.1300/J233v04n03.
43. Sifaneck, S.J., Ream, G.L., Johnson, B.D., Dunlap, E., Retail marijuana purchases in designer and commercial markets in New York City: sales units, weights, and prices per gram. Drug Alcohol Depend. 90 (2007), 40–51, 10.1016/j.drugalcdep.2006.09.013.
44. Stogner, J.M., Miller, B.L., Assessing the dangers of dabbing: mere marijuana or harmful new trend?. Pediatrics 136 (2015), 1–3, 10.1542/peds.2015-0454.
45. Taskin, D.P., How beneficial is vaping cannabis to respiratory health compared to smoking?. Addiction 110 (2015), 1706–1707, 10.1093/pubmed/fdv005.
46. Thomas, C., Freisthler, B., Examining the locations of medical marijuana dispensaries in Los Angeles. Drug Alcohol Rev., 2015, 10.1111/dar.12325.
47. Thurston, C., Lieberman, S.A., Schmiege, S.J., Medical marijuana diversion and associated problems in adolescent substance treatment. J. Am. Acad. Child Adolesc. Psychiatry 51 (2011), 694–702.
48. Watters, J.K., Biernacki, P., Targeted sampling: options for the study of hidden populations. Soc. Prob. 36 (1989), 416–430.
49. Wilkinson, S.T., Yarnell, S., Radhakrishnan, R., Ball, S.A., D'souza, D.C., Marijuana legalization: impact on physicians and public health. Annu. Rev. Med. 67 (2016), 453–466.
50. Woodruff, S.I., Shillington, A.M., Sociodemographic and drug use severity differences between medical marijuana users and non-medical users visiting the emergency department. Am. J. Addict., 1–7, 2016, 10.1111/ajad.12401.